Glucose/fructose/phosphoric acid
(Redirected from Emetrol)
.jpg) | |
| Combination of | |
|---|---|
| Glucose | Monosaccharide |
| Fructose | Monosaccharide |
| Phosphoric acid | Acid |
| Clinical data | |
| Trade names | Emetrol |
| AHFS/Drugs.com | Consumer Drug Information |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
Glucose/fructose/phosphoric acid (trade name Emetrol) is an over-the-counter antiemetic taken to relieve nausea and vomiting. Made by WellSpring Pharmaceutical Corporation, it was formerly distributed by McNeil Consumer Healthcare.
History
Emetrol was created by Kinney and Company of Columbus, Indiana and was first used in 1949.[1]
It is a phosphorated carbohydrate solution, and comes in syrup form.
Contraindications
Since Emetrol contains fructose it is contraindicated for people with hereditary fructose intolerance (HFI). In diabetes patients, it can cause potentially harmful hyperglycaemia (high blood sugar).[2]
References
- ^ "History of Emetrol, a Classic American Remedy for Nausea". Archived from the original on 2011-03-05.
- ^ Consumer Drug Information
External links
 | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
Categories:
- Articles with short description
- Short description matches Wikidata
- Chemicals that do not have a ChemSpider ID assigned
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Articles containing unverified chemical infoboxes
- Drugs that are a combination of chemicals
- Antiemetics
- Products introduced in 1949
- Combination drugs
- All stub articles
- Gastrointestinal system drug stubs